TXA | News

Our Recent Posts

WOMAN-PharmacoTXA Trial
March 15, 2021 Uncategorized Bash

The WOMAN-PharmacoTXA trial is a randomised controlled trial to assess the pharmacokinetics and pharmacodynamics of intramuscular, intravenous, and oral administration of tranexamic acid in women giving birth by caesarean section

Details
World Health Organization reacts to the WOMAN Trial results
November 27, 2020 Uncategorized Bash

In response to the release of the WOMAN trial results, the World Health Organisation (WHO) department of reproductive health and research is working with the Cochrane Pregnancy and Childbirth group to fast-track the update of the existing Cochrane systematic review on the treatment of primary postpartum hemorrhage (PPH) with priority given to the use of

Details
Trauma-INTACT Results
November 27, 2020 Uncategorized Bash

The Trauma Intact trial: a clinical trial investigating pharmacokinetics of intramuscular tranexamic acid (TXA) in bleeding trauma patients TXA a drug that prevents severe bleeding after injury by inhibiting blood clot breakdown, is most effective when given soon after injury. Every 15 minutes treatment delay reduces its lifesaving potential by 10%. However, currently only 3%

Details
Nigerian Health Minister To Support the WOMAN-trial
November 18, 2020 Uncategorized Bash

Nigeria’s health minister, Professor Isaac Adewale has said that deaths of women due to postpartum haemorrhage (PPH), a severe form of bleeding after childbirth, was a huge problem in Nigeria and that he will promote the use of tranexamic acid to reduce these deaths. “This drug is not new in Nigeria, but now we want

Details